Zevra Therapeutics Stock Zoomed: Why the 21% Jump Happened
Zevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Understanding what stocks are favored by new investors can guide your choices. Explore current buying trends to make informed decisions.
27,622 articlesZevra Therapeutics stock zoomed after a strong earnings release, delivering revenue growth and a first GAAP profit. T...
Rigetti Computing shares slid in a choppy week as inflation jitters and noisy peers weighed on sentiment. This guide ...
A midweek rally lifted U.S. stocks as investors weighed geopolitical headlines and a high-profile IPO. The Nasdaq led...
A sharp drop in Planet Labs shares sparked questions about growth, cash burn, and contract momentum. This guide break...
As March 2026 brings renewed market volatility, investors are weighing public alternatives to Public.com. This report...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
A major enterprise deal could unlock rapid upside for Nebius NBIS. This article breaks down how the contract might af...
When a biotech CEO sells shares after exercising options, investors rightly pause to interpret the move. This article...
Buffett's latest caution mirrors his Dot-Com-era warnings. In a market buzzing with hype, where does prudence fit in?...
When a tech titan speaks, markets listen. This article breaks down NVIDIA's latest signals from the GTC AI conference...
June's session brought a Dow shakeup and telecom headlines that rattled Verizon. Learn what happened, why it matters,...
SpaceX raised $25 billion through a bond offering that received top ratings from credit agencies, yet the stock still...